Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001855763-22-000003

Options or other derivatives

  • Director acquired 3,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
REESE ALBERT L JR Director 2022-03-08 Grant or award · Stock Options +3,400 6,800 D
Loading xslF345X03/primary_doc.xml…